ROTH MKM (“Roth”), www.roth.com, a relationship-driven investment bank focused on serving growth companies and their investors, today announced that Jason Wittes has joined the firm’s healthcare research team, as Managing Director, Senior Research Analyst. His research coverage is expected to include small and large cap Medical Technology and Biotechnology companies.
Prior to joining Roth, Mr. Wittes was the head of healthcare research at Loop Capital. Previously Jason led public medical technology investment and business development for Fosun International. Jason focuses on a wide range of Medical Technology and Biotechnology companies with an emphasis on technology, product cycles, clinical data and real-world outcomes evaluation. His research has been recognized by a variety of industry polls, including The Wall Street Journal's Best on the Street.
Mr. Wittes has a B.S. in Chemistry from Carnegie Mellon University and an M.B.A. from New York University’s Stern School of Business.
Jeff Martin, CFA and Co-Director of Research commented, “We are excited to welcome Jason Wittes to the Healthcare team here at Roth. Jason brings a long history and valuable perspective surrounding the historical and emerging trends within medical technology and biotechnology sectors. These insights should prove extremely valuable for our clients.”
Mr. Wittes stated, “I am thrilled to join the Roth healthcare team. Roth has a well-established legacy in healthcare and the recent merger with MKM adds significant distribution capabilities to the equation. I look forward to contributing to the legacy by providing, high quality fundamental research and stock calls. As I’ve done throughout my career my goal is to focus on innovative technologies with the most investment potential.”
“We are excited to have Jason join our healthcare research team,” said Sagar Sheth, CEO of Roth. “His diverse experience in a variety of medical technologies across the market cap spectrum is an excellent fit for our research platform. I’m confident that Jason’s expertise will provide valuable insights for clients and help build upon our long track record in the healthcare sector.”
Since 2010, ROTH has been involved in approximately 570 transactions for its Healthcare clients, with total transaction value over $25.0 billion. (Source: Roth | 09/25/2023)
About ROTH MKM
ROTH MKM is a relationship-driven investment bank focused on serving growth companies and their investors. Our full service platform provides capital raising, high impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory and corporate access. Headquartered in Newport Beach, California, ROTH MKM is a privately-held, employee owned organization and maintains offices throughout the U.S. For more information, please visit www.roth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231012447196/en/
Contacts
Investor and Media Contact: ROTH MKM, Isabel Mattson-Pain, Director of Marketing, Imattson-pain@roth.com, 949-720-7117.
